Philippe Gaulard Selected Research

T-Cell Lymphoma (Lymphoma, T Cell)

5/2022	Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.
1/2022	Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.
1/2021	Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
1/2021	Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.
1/2020	Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.
11/2018	Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma.
10/2016	Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.
3/2015	Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.
5/2014	Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
11/2012	Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Gaulard Research Topics

Disease

41	Lymphoma (Lymphomas) 07/2022 - 03/2002
30	Neoplasms (Cancer) 05/2022 - 06/2003
22	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 03/2002
20	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2002
19	T-Cell Lymphoma (Lymphoma, T Cell) 05/2022 - 07/2003
12	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 11/2012
12	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 02/2002
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 02/2006
7	Hodgkin Disease (Hodgkin's Disease) 10/2016 - 12/2003
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 12/2003
4	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2020 - 10/2009
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2010 - 10/2002
2	Inflammation (Inflammations) 04/2020 - 01/2020
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 08/2017 - 05/2014
2	Neutropenia 08/2017 - 07/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2016 - 02/2012
2	Hematologic Neoplasms (Hematological Malignancy) 02/2016 - 11/2013
2	Extranodal NK-T-Cell Lymphoma 05/2014 - 02/2011
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2012 - 02/2005
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	Fatigue 01/2020
1	Agranulocytosis (Granulocytopenia) 01/2019
1	Large Granular Lymphocytic Leukemia 01/2019
1	Disease Progression 12/2016
1	Hyperplasia 10/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Pathologic Complete Response 03/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2014

Drug/Important Bio-Agent (IBA)

16	Rituximab (Mabthera)FDA Link 01/2021 - 01/2002
11	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2002
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2002
10	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2002
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2002
9	Biological ProductsIBA 01/2022 - 11/2005
8	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 07/2003
8	Proteins (Proteins, Gene)FDA Link 08/2017 - 06/2003
6	Biomarkers (Surrogate Marker)IBA 12/2019 - 03/2007
5	AntigensIBA 04/2020 - 01/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2009
4	Anaplastic Lymphoma KinaseIBA 01/2021 - 11/2012
4	ParaffinIBA 01/2018 - 04/2003
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 11/2013
3	Gemcitabine FDA Link 01/2022 - 11/2013
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 02/2011
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 08/2017
3	Azacitidine (5 Azacytidine)FDA Link 11/2018 - 07/2014
3	RNA (Ribonucleic Acid)IBA 01/2018 - 06/2013
3	Brentuximab VedotinIBA 01/2017 - 11/2014
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2016 - 02/2012
3	Messenger RNA (mRNA)IBA 11/2014 - 04/2003
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 11/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 11/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 04/2003
2	5-hydroxymethylcytosineIBA 01/2018 - 08/2017
2	Janus KinasesIBA 01/2018 - 08/2009
2	AntibodiesIBA 07/2016 - 05/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 02/2005
2	Interleukin-4 (Interleukin 4)IBA 04/2015 - 07/2004
2	Bleomycin (Blenoxane)FDA LinkGeneric 12/2014 - 01/2003
2	Monoclonal AntibodiesIBA 08/2011 - 01/2002
2	Methotrexate (Mexate)FDA LinkGeneric 02/2011 - 01/2003
2	Granzymes (Granzyme)IBA 02/2010 - 03/2007
2	Azathioprine (Imuran)FDA LinkGeneric 01/2010 - 11/2009
2	Transcription Factors (Transcription Factor)IBA 01/2003 - 01/2003
1	CytokinesIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	SteroidsIBA 01/2022
1	romidepsin (FK228)FDA Link 01/2022
1	NivolumabIBA 01/2022
1	PlatinumIBA 01/2021
1	Alemtuzumab (Campath)FDA Link 01/2021
1	LigandsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Capsules (Microcapsules)IBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017
1	Protein Isoforms (Isoforms)IBA 10/2017
1	CytosineIBA 08/2017
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	alpha-hydroxyglutarateIBA 12/2016
1	Arginine (L-Arginine)FDA Link 12/2016
1	Bendamustine Hydrochloride FDA Link 12/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	Glutamine (L-Glutamine)FDA Link 02/2016
1	Exportin 1 ProteinIBA 01/2016
1	GlycolipidsIBA 01/2016
1	AnthracyclinesIBA 11/2015
1	Tumor Biomarkers (Tumor Markers)IBA 12/2014
1	Vindesine (Vindesin)IBA 12/2014

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 05/2022 - 01/2002
16	Therapeutics 05/2022 - 02/2002
6	Breast Implants (Breast Implant) 01/2021 - 01/2018
4	Stem Cell Transplantation 01/2021 - 11/2011
3	Combination Drug Therapy (Combination Chemotherapy) 01/2017 - 03/2007
2	Kidney Transplantation 01/2021 - 12/2003
2	Induction Chemotherapy 01/2020 - 08/2005
1	Lymph Node Excision (Lymph Node Dissection) 07/2022
1	Ligation 01/2020
1	Splenectomy 01/2019
1	Injections 01/2016